Your browser doesn't support javascript.
loading
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Thyssen, Jacob P; Bewley, Anthony; Ständer, Sonja; Castro, Carla; Misery, Laurent; Kim, Brian S; Biswas, Pinaki; Chan, Gary; Myers, Daniela E; Watkins, Melissa; Alderfer, Justine; Güler, Erman; Silverberg, Jonathan I.
  • Thyssen JP; Department of Dermatology and Wound Healing, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Bewley A; Barts Health NHS Trust, London, UK.
  • Ständer S; Center for Chronic Pruritus, Münster University Hospital, Münster, Germany.
  • Castro C; Pediatric Dermatology, Hospital Universitario Austral, Pilar, Argentina.
  • Misery L; University Hospital of Brest, Brest, France.
  • Kim BS; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Biswas P; Pfizer Inc., New York, New York, USA.
  • Chan G; Pfizer Inc., Groton, Connecticut, USA.
  • Myers DE; Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Watkins M; Pfizer Inc., New York, New York, USA.
  • Alderfer J; Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Güler E; Pfizer Inc., Istanbul, Turkey.
  • Silverberg JI; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Dermatology ; 240(2): 243-253, 2024.
Article en En | MEDLINE | ID: mdl-38081155

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Dermatitis Atópica Límite: Adolescent / Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Dermatitis Atópica Límite: Adolescent / Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article